Message Font: Serif | Sans-Serif
 
UnThreaded | Threaded | Whole Thread (4) | Ignore Thread Prev | Next
Author: captainccs Big funky green star, 20000 posts Top Favorite Fools 10+ Year Anniversary! Old School Fool Add to my Favorite Fools Ignore this person (you won't see their posts anymore) Number: of 19131  
Subject: Drug patents Date: 3/13/2012 10:12 AM
Post New | Post Reply | Reply Later | Create Poll . Report this Post | Recommend it!
Recommendations: 5
Good news or bad news depending on which side of the fence you are on. Patents are, of course, a government granted privilege (not "right") for the purpose of encouraging risk taking in the development of new products. What a government gives it has the right to take away. But if the purpose was to encouraging risk taking wouldn't this move signal the exact opposite and stop companies from developing new, expensive drugs.

That's the opinion I would have held a few years ago but, seeing the emergence of free (Open Source) software, which initially was resisted by the big software houses but which now is very much part of the scene, I wonder how a patent free drug economy would work.


Analysis: India cancer ruling opens door for cheaper drugs
By Kaustubh Kulkarni and Henry Foy | Reuters – 1 hr 27 mins ago

MUMBAI (Reuters) - India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.

On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug cheaply in India.

It is only the second time a nation has issued a compulsory license for a cancer drug after Thailand did so on four drugs between 2006 and 2008, also on affordability grounds. Thailand also issued licenses for HIV/AIDS and heart disease treatments.


http://news.yahoo.com/analysis-india-patent-ruling-may-open-...

Denny Schlesinger
Post New | Post Reply | Reply Later | Create Poll . Report this Post | Recommend it!
Print the post  
UnThreaded | Threaded | Whole Thread (4) | Ignore Thread Prev | Next

Announcements

Post of the Day:
Macro Economics

Intel's Broadwell Potential
What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and "#1 Media Company to Work For" (BusinessInsider 2011)! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement